4D Molecular Therapeutics (FDMT) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free FDMT Stock Alerts $25.34 -0.30 (-1.17%) (As of 05/17/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media 4D Molecular Therapeutics Short Interest DataCurrent Short Volume9,620,000 sharesPrevious Short Volume9,830,000 sharesChange Vs. Previous Month-2.14%Dollar Volume Sold Short$230.21 millionShort Interest Ratio / Days to Cover11.1Last Record DateApril 30, 2024Outstanding Shares51,700,000 sharesPercentage of Shares Shorted18.61%Today's Trading Volume438,600 sharesAverage Trading Volume936,930 sharesToday's Volume Vs. Average47% Short Selling 4D Molecular Therapeutics ? Sign up to receive the latest short interest report for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFDMT Short Interest Over TimeFDMT Days to Cover Over TimeFDMT Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. 4D Molecular Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,620,000 shares $230.21 million -2.1%N/A11.1 $23.93 4/15/20249,830,000 shares $258.04 million +5.5%N/A8.3 $26.25 3/31/20249,320,000 shares $296.94 million +9.7%N/A8 $31.86 3/15/20248,500,000 shares $267.84 million +1.9%N/A7.7 $31.51 2/29/20248,340,000 shares $233.69 million +18.1%N/A7.8 $28.02 2/15/20247,060,000 shares $195.49 million +83.9%N/A7.1 $27.69 Get the Latest News and Ratings for FDMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for 4D Molecular Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20243,840,000 shares $66.24 million +33.3%N/A4.3 $17.25 1/15/20242,880,000 shares $54.14 million -10.6%N/A7.7 $18.80 12/31/20233,220,000 shares $65.24 million -18.1%N/A8.8 $20.26 12/15/20233,930,000 shares $69.80 million +9.2%N/A10.8 $17.76 11/30/20233,600,000 shares $45.79 million -4.5%N/A10.6 $12.72 11/15/20233,770,000 shares $41.70 million +7.4%N/A11.2 $11.06 10/31/20233,510,000 shares $37.70 million -14.4%N/A10.6 $10.74 10/15/20234,100,000 shares $42.89 million +4.3%N/A13 $10.46 9/30/20233,930,000 shares $50.03 million +6.5%N/A13.6 $12.73 9/15/20233,690,000 shares $57.42 million +3.4%N/A12.3 $15.56 8/31/20233,570,000 shares $58.12 million No ChangeN/A9.4 $16.28 8/15/20233,570,000 shares $59.48 million +15.5%N/A8.6 $16.66 7/31/20233,090,000 shares $56.55 million -0.6%N/A6.5 $18.30 7/15/20233,110,000 shares $58.84 million -11.4%N/A5.3 $18.92 6/30/20233,510,000 shares $63.43 million +2.6%N/A5.5 $18.07 6/15/20233,420,000 shares $71.82 million +10.0%N/A5.4 $21.00 5/31/20233,110,000 shares $57.10 million +4.7%N/A5.2 $18.36 5/15/20232,970,000 shares $52.93 million +4.6%N/A5.4 $17.82 4/30/20232,840,000 shares $51.15 million -10.1%N/A5.6 $18.01 4/15/20233,160,000 shares $51.10 million +1.3%N/A8 $16.17 3/31/20233,120,000 shares $53.63 million +19.5%N/A8.8 $17.19 3/15/20232,610,000 shares $45.34 million +23.7%N/A7.6 $17.37 2/28/20232,110,000 shares $40.60 million -5.4%N/A6.3 $19.24 2/15/20232,230,000 shares $41.19 million +2.8%N/A6.1 $18.47 1/31/20232,170,000 shares $45.68 million -3.6%N/A4.5 $21.05 1/15/20232,250,000 shares $49.57 million +8.7%N/A4.4 $22.03 12/30/20222,070,000 shares $45.97 million +11.9%N/A3.9 $22.21 12/15/20221,850,000 shares $42.72 million -19.2%N/A3.2 $23.09 11/30/20222,290,000 shares $55.35 million -15.2%N/A4.2 $24.17 11/15/20222,700,000 shares $50.46 million -6.9%N/A5.5 $18.69 10/31/20222,900,000 shares $25.11 million -1.7%N/A9.1 $8.66 10/15/20222,950,000 shares $20.74 million +87.9%N/A10.6 $7.03 9/30/20221,570,000 shares $12.62 million +7.5%N/A6.3 $8.04 9/15/20221,460,000 shares $13.49 million -2.7%N/A7.6 $9.24The Overlooked Retirement Asset You Probably Don’t Own (Ad)4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. FDMT Short Interest - Frequently Asked Questions What is 4D Molecular Therapeutics' current short interest? Short interest is the volume of 4D Molecular Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 9,620,000 shares of FDMT short. Learn More on 4D Molecular Therapeutics' current short interest. What is a good short interest ratio for 4D Molecular Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FDMT shares currently have a short interest ratio of 11.0. Learn More on 4D Molecular Therapeutics's short interest ratio. Which institutional investors are shorting 4D Molecular Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of 4D Molecular Therapeutics: Ikarian Capital LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is 4D Molecular Therapeutics' short interest increasing or decreasing? 4D Molecular Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 9,620,000 shares, a decline of 2.1% from the previous total of 9,830,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does 4D Molecular Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to 4D Molecular Therapeutics: Vir Biotechnology, Inc. (6.63%), Tarsus Pharmaceuticals, Inc. (20.28%), Cullinan Oncology, Inc. (10.23%), Neumora Therapeutics, Inc. (12.27%), Scholar Rock Holding Co. (16.78%), BioCryst Pharmaceuticals, Inc. (16.30%), Autolus Therapeutics plc (1.32%), Immatics (10.50%), ProKidney Corp. (22.89%), Inhibrx, Inc. (4.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short 4D Molecular Therapeutics stock? Short selling FDMT is an investing strategy that aims to generate trading profit from 4D Molecular Therapeutics as its price is falling. FDMT shares are trading down $0.30 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against 4D Molecular Therapeutics? A short squeeze for 4D Molecular Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FDMT, which in turn drives the price of the stock up even further. How often is 4D Molecular Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FDMT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Vir Biotechnology Short Interest Tarsus Pharmaceuticals Short Interest Cullinan Oncology Short Interest Neumora Therapeutics Short Interest Scholar Rock Short Interest BioCryst Pharmaceuticals Short Interest Autolus Therapeutics Short Interest Immatics Short Interest ProKidney Short Interest Inhibrx Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FDMT) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders